Drug Dependence Clinical Trial
NCT number | NCT00005765 |
Other study ID # | NCRR-M01RR00109-0747 |
Secondary ID | M01RR000109 |
Status | Completed |
Phase | N/A |
First received | June 1, 2000 |
Last updated | June 23, 2005 |
The objective of this protocol is to examine the utility of behavioral economics for understanding reinforcer interactions as they pertain to drug self-administration. In a series of 6 experiments, the researchers will attempt to quantify the effects of qualitatively different reinforcers (money, cigarettes, alcohol, nicotine gum) and their interactions. This work represents a continuation of research by this investigator in the area of addiction and pharmacology.
Status | Completed |
Enrollment | 0 |
Est. completion date | |
Est. primary completion date | |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 21 Years to 50 Years |
Eligibility |
Inclusion Criteria: - Use of 20 or more cigarettes per day - CO levels >15 ppm - More than 12 alcohol drinks per week and beer as preferred alcoholic beverage |
Observational Model: Natural History, Time Perspective: Cross-Sectional
Country | Name | City | State |
---|---|---|---|
United States | University of Vermont | Burlington | Vermont |
Lead Sponsor | Collaborator |
---|---|
National Center for Research Resources (NCRR) |
United States,
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02564341 -
Targeting Effective Analgesia in Clinics for HIV - Intervention
|
N/A | |
Completed |
NCT02224508 -
Evaluation of a Health Plan Initiative to Mitigate Chronic Opioid Therapy Risks
|
N/A | |
Completed |
NCT00593463 -
Drug Discrimination in Methadone-Maintained Humans Study 1
|
Phase 1 | |
Completed |
NCT03678051 -
CBT4CBT for Women in Residential Treatment for Substance Use Disorders
|
N/A | |
Recruiting |
NCT04003948 -
Preliminary Efficacy and Safety of Ibogaine in the Treatment of Methadone Detoxification
|
Phase 2 | |
Withdrawn |
NCT05440721 -
Clinical Trial of an Innovative Digital Therapeutic for Smoking Cessation With Biochemical Verification
|
N/A | |
Completed |
NCT03694327 -
Innovative Digital Therapeutic for Smoking Cessation
|
N/A | |
Completed |
NCT01449981 -
Development and Testing of Adolescent Twelve-Step Facilitation
|
N/A | |
Completed |
NCT00183118 -
Russia PREVENT (HIV Prevention Partnership in Russian Alcohol Treatment)
|
Phase 1/Phase 2 | |
Completed |
NCT00047866 -
Brain Function in Response to Motivational Stimuli
|
N/A | |
Recruiting |
NCT03333460 -
Transcranial Magnetic Stimulation for Cocaine Addiction
|
N/A | |
Completed |
NCT02124980 -
Automated Recovery Line for Medication Assisted Treatment
|
N/A | |
Terminated |
NCT00975416 -
Oxytocin and Cognitive Behavioral Therapy in Drug Dependence
|
Phase 4 | |
Completed |
NCT00265512 -
LINK: Aftercare Monitoring Project
|
N/A | |
Completed |
NCT00706901 -
Impact of Group Motivational Interviewing and In-Home-Messaging-Devices for Dually Diagnosed Veterans
|
N/A | |
Completed |
NCT02656745 -
Clinical Trial of Smoking Cessation Mobile Phone Program
|
N/A | |
Withdrawn |
NCT00675532 -
Testing a Primary Care Model for the Treatment of Opioid Dependence Using Long-acting Injectable Naltrexone (Vivitrol).
|
N/A | |
Active, not recruiting |
NCT03539575 -
CB1R in Synthetic Psychoactive Cannabinoids
|
N/A | |
Completed |
NCT01246401 -
Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations
|
Phase 1/Phase 2 | |
Completed |
NCT01096550 -
Intensive Outpatient Versus Outpatient Treatment With Buprenorphine Among African Americans
|
N/A |